Amarantus Bioscience Holdings Inc (AMBS)

[JJAAMMAANN]

Maybe MANF could be the Rabbit this Monday at the conference?

Maybe WallachBeth Capital will come through with something?

http://ir.amarantus.com/press-releases/detail/2034/amarantus-retains-wallachbeth-capital-to-evaluate-strategic

With Orphan Drug Designations for MANF in Retinal Artery Occlusion and Retinitis Pigmentosa, I'm sure someone wants to get a piece of the action...Maybe GC is finally willing to ask for help from one of the big Pharma Companies...

The FDA Orphan Drug Designation program provides a special status to drugs and biologics intended to treat, diagnose or prevent so-called orphan diseases and disorders that affect fewer than 200,000 people in the U.S. This designation provides for a seven-year marketing exclusivity period against competition, as well as certain incentives, including federal grants, tax credits and a waiver of PDUFA filing fees.

Sounds pretty appealing to me...especially with Two ODD's already.

In My Own Personal Opinion Of Course!
Long AMBS!